Claris Lifesciences completes its stake sale in Otsuka Pharmaceuticals

India Infoline News Service | Mumbai | September 21, 2017 14:42 IST

Claris Lifesciences announced on Thursday that the company has completed the sale of its remaining 20% stake in Otsuka Pharmaceuticals India Private Limited.

Claris Lifesciences announced on Thursday that the company has completed the sale of its remaining 20% stake in Otsuka Pharmaceuticals India Private Limited, a joint venture with Otsuka Pharmaceutical Factory, Inc and Mitsui & Co, to Otsuka Pharmaceutical Factory, Inc (Japan) for a consideration of USD 20 million.

Claris Lifesciences hit an intraday high of Rs 383.90 per share and an intraday low of Rs 372 per share on BSE on September 21, 2017. The stock witnessed a spurt in volume by more than 3.64 times on BSE. The stock had hit its 52-week high of Rs 430.10 per share on December 16, 2016 and its 52-week low of Rs 221.50 per share on September 29, 2016.  

At 1407 hours, the stock was trading at Rs 375, up by 0.47% on BSE on Thursday. Meanwhile, NSE Nifty was trading at 10,108.30 level, down by 32.85 points or 0.32% and S&P BSE Sensex was trading at 32,321.22 level, lower by 79.29 points or 0.24% around the same time on Thursday.

Claris Lifesciences is engaged in the business of manufacturing drugs and pharmaceutical products with a strong geographical presence in India as well as around the globe. 

***Note: This is a BSE Chart

Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.

 

Advertisements

  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.